Financiën Eli Lilly and Company

Aandelen

LLY

US5324571083

Farmaceutische producten

Beurs gesloten - Nyse Andere beurzen 22:00:02 13-06-2025			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
819,36 ^USD	+0,90%		+6,43%	+6,13%

15/06	Eli Lilly's Eloralintide verlaagt gewicht in vroege klinische studie	MT
14/06	Experimenteel geneesmiddel tegen obesitas van Eli Lilly leidt tot meer dan 11% gewichtsverlies in vroege fase van onderzoek	RE

Voorlopige winst- en verliesrekening: Eli Lilly and Company

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Omzet ¹	24.540	28.318	28.541	34.124	45.043	59.567	71.416	83.415
Variatie	-	15,4%	0,79%	19,56%	32%	32,25%	19,89%	16,8%
EBITDA ¹	8.589	10.005	9.472	8.584	16.079	26.177	34.186	41.082
Variatie	-	16,48%	-5,32%	-9,38%	87,32%	62,8%	30,59%	20,17%
Bedrijfsresultaat (EBIT) ¹	7.265	8.457	7.950	7.057	14.313	24.233	32.091	38.982
Variatie	-	16,41%	-6%	-11,24%	102,83%	69,31%	32,43%	21,47%
Betaalde rente ¹	-326,6	-314,4	-268,8	-312,3	-605,4	-776	-620,9	-709,8
Resultaat voor belastingen (EBT) ¹	7.230	6.156	6.806	6.555	12.680	23.182	29.575	34.676
Variatie	-	-14,86%	10,57%	-3,7%	93,46%	82,82%	27,58%	17,25%
Nettowinst (verlies) ¹	6.194	5.582	6.245	5.240	10.590	19.105	25.193	30.655
Variatie	-	-9,88%	11,88%	-16,08%	102,08%	80,4%	31,87%	21,68%
Datum van publicatie	29/01/21	3/02/22	2/02/23	6/02/24	6/02/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Fiscaal tijdperk: december	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Omzet ¹	5.499	5.741	7.440	6.806	6.740	6.773	8.000	7.810	6.488	6.942	7.302	6.960	8.312	9.499	9.353	8.768	11.303	11.439	13.533	12.728	14.372	15.359	16.926	15.983	17.298	17.798	19.602
Variatie	-	4,39%	29,6%	-8,53%	-0,96%	0,49%	18,12%	-2,37%	-16,93%	6,99%	5,19%	-4,68%	19,43%	14,27%	-1,53%	-6,26%	28,91%	1,21%	18,3%	-5,94%	12,91%	6,87%	10,2%	-5,57%	8,23%	2,89%	10,14%
EBITDA ¹	1.865	1.865	2.824	2.223	2.353	2.446	2.982	3.046	1.679	2.373	2.375	1.982	2.618	986,4	2.855	3.049	4.268	2.213	6.113	4.281	6.782	7.517	8.557	8.243	-	-	-
Variatie	-	-0,04%	51,43%	-21,26%	5,85%	3,96%	21,88%	2,15%	-44,88%	41,34%	0,09%	-16,54%	32,1%	-62,33%	189,46%	6,78%	40%	-48,14%	176,19%	-29,97%	58,43%	10,83%	13,85%	-3,67%	-	-	-
Bedrijfsresultaat (EBIT) ¹	1.541	1.506	2.456	1.873	1.984	2.064	2.536	2.610	1.330	2.010	2.000	1.620	2.252	575,4	2.468	2.648	3.854	1.747	5.628	3.818	6.079	6.704	7.331	7.078	8.504	8.818	10.519
Variatie	-	-2,26%	63,06%	-23,74%	5,93%	4,04%	22,86%	2,92%	-49,04%	51,13%	-0,5%	-19,01%	39,04%	-74,45%	328,83%	7,32%	45,53%	-54,66%	222,1%	-32,16%	59,22%	10,28%	9,34%	-3,44%	20,14%	3,69%	19,29%
Charge d'intérêts ¹	-81,2	-83,8	-83,4	-82,3	-86,9	-76,6	-74	-77,9	-71	-61,4	-58,5	-68,6	-74,3	-75,7	-93,7	-133,8	-146,3	-144,9	-180,4	-195,4	-200	-210	-210	-	-	-	-
Resultaat voor belastingen (EBT) ¹	-	-	-	1.476	1.594	1.245	-	-	-	-	-	-	2.089	427,2	2.509	2.536	3.517	1.588	5.039	3.456	5.688	6.181	6.602	-	-	-	-
Variatie	-	-	-	-	7,96%	-21,87%	-	-	-	-	-	-	-	-79,55%	487,27%	1,09%	38,69%	-54,84%	217,22%	-31,41%	64,58%	8,67%	6,81%	-	-	-	-
Nettowinst (verlies) ¹	1.412	1.208	2.117	1.355	1.390	1.110	1.726	1.903	952,5	1.452	1.938	1.345	1.763	-57,4	2.190	2.243	2.967	970,3	4.410	2.759	4.733	5.377	6.088	5.918	-	-	-
Variatie	-	-14,42%	75,17%	-35,97%	2,58%	-20,15%	55,49%	10,24%	-49,94%	52,41%	33,48%	-30,59%	31,1%	-103,26%	3.914,63%	2,43%	32,28%	-67,3%	354,48%	-37,43%	71,55%	13,59%	13,23%	-2,79%	-	-	-
Datum van publicatie	30/07/20	27/10/20	29/01/21	27/04/21	3/08/21	26/10/21	3/02/22	28/04/22	4/08/22	1/11/22	2/02/23	27/04/23	8/08/23	2/11/23	6/02/24	30/04/24	8/08/24	30/10/24	6/02/25	1/05/25	-	-	-	-	-	-	-

¹USD in Miljoen

Geschatte gegevens

Balansprognose: Eli Lilly and Company

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Nettoschuld ¹	12.914	12.976	14.027	22.298	30.221	24.786	12.186	-5.447
Variatie	-	0,48%	8,1%	58,96%	35,53%	-17,98%	-50,84%	-144,7%
Datum van publicatie	29/01/21	3/02/22	2/02/23	6/02/24	6/02/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte kasstroom: Eli Lilly and Company

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
CAPEX ¹	1.388	1.310	1.854	3.448	5.058	5.434	5.872	5.630
Variatie	-	-5,63%	41,57%	85,92%	46,7%	7,43%	8,07%	-4,12%
Vrije kasstroom (FCF) ¹	5.112	5.951	5.230	792,5	3.760	13.045	16.342	22.711
Variatie	-	16,42%	-12,11%	-84,85%	374,46%	246,92%	25,28%	38,97%
Datum van publicatie	29/01/21	3/02/22	2/02/23	6/02/24	6/02/25	-	-	-

¹USD in Miljoen

Geschatte gegevens

Verwachte financiële ratio's: Eli Lilly and Company

Fiscaal tijdperk: december	2020	2021	2022	2023	2024	2025	2026	2027
Winstgevendheid
EBITDA-marge (%)	35%	35,33%	33,19%	25,15%	35,7%	43,95%	47,87%	49,25%
EBIT-marge (%)	29,6%	29,86%	27,85%	20,68%	31,78%	40,68%	44,93%	46,73%
EBT-marge (%)	29,46%	21,74%	23,85%	19,21%	28,15%	38,92%	41,41%	41,57%
Nettomarge (%)	25,24%	19,71%	21,88%	15,36%	23,51%	32,07%	35,28%	36,75%
FCF-marge (%)	20,83%	21,01%	18,32%	2,32%	8,35%	21,9%	22,88%	27,23%
Vrije kasstroom/nettoresultaat (%)	82,53%	106,61%	83,75%	15,12%	35,51%	68,28%	64,87%	74,09%
Winstgevendheid
ROA	14,42%	15,58%	14,62%	9,23%	14,84%	22,28%	24,79%	25,43%
ROE	175,45%	101,73%	73,22%	48,93%	84,84%	96,53%	74,67%	59,33%
Financiële gezondheid
Hefboom (schuld/ebitda)	1,5x	1,3x	1,48x	2,6x	1,88x	0,95x	0,36x	-
Schuld/vrije kasstroom	2,53x	2,18x	2,68x	28,14x	8,04x	1,9x	0,75x	-
Kapitaalintensiteit
Kapitaaluitgaven/omzet (%)	5,66%	4,63%	6,5%	10,1%	11,23%	9,12%	8,22%	6,75%
CAPEX / EBITDA (%)	16,16%	13,09%	19,58%	40,16%	31,46%	20,76%	17,18%	13,7%
CAPEX / FCF (%)	27,15%	22,01%	35,45%	435,03%	134,51%	41,65%	35,93%	24,79%
Bestanddelen per aandeel
Kasstroom per aandeel ¹	7,119	7,964	7,831	4,694	9,754	18,18	33,37	36,56
Variatie	-	11,87%	-1,67%	-40,06%	107,79%	86,39%	83,58%	9,56%
Dividend per aandeel ¹	2,96	3,4	3,92	4,52	5,2	5,994	6,697	7,534
Variatie	-	14,86%	15,29%	15,31%	15,04%	15,28%	11,73%	12,48%
Nettoactief per aandeel ¹	5,9	9,411	11,2	11,93	15,76	29,21	47,54	72,61
Variatie	-	59,51%	19,04%	6,45%	32,16%	85,31%	62,79%	52,71%
WPA ¹	6,79	6,12	6,9	5,8	11,71	21,21	28,11	34,14
Variatie	-	-9,87%	12,75%	-15,94%	101,9%	81,1%	32,53%	21,46%
Aantal aandelen (in duizend)	906.582	906.592	950.178	899.307	900.432	897.736	897.736	897.736
Datum van publicatie	29/01/21	3/02/22	2/02/23	6/02/24	6/02/25	-	-	-